会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 6. 发明授权
    • Thiophenopyrimidines
    • 噻吩并嘧啶
    • US06469166B2
    • 2002-10-22
    • US09896250
    • 2001-06-29
    • Thomas R. WebbChen ChenJames R. McCarthyTerence J. Moran
    • Thomas R. WebbChen ChenJames R. McCarthyTerence J. Moran
    • C07D49504
    • C07D495/04
    • This invention concerns compounds of formula including the stereoisomers and the pharmaceutically acceptable acid addition salt forms thereof, wherein X is S, SO or SO2; R1 is NR4R5 or OR5; R2 is C1-6alkyl, C1-6alkyloxy or C1-6alkylthio; R3 is hydrogen, C1-6alkyl, C1-6alkylsulfonyl, C1-6alkylsulfoxy or C1-6alkylthio; R4 is hydrogen, C1-6alkyl, mono- or di(C3-6cycloalkyl)methyl, C3-6cycloalkyl, C3-6alkenyl, hydroxyC1-6alkyl, C1-6alkylcarbonyloxyC1-6alkyl or C1-6alkyloxyC1-6alkyl; R5 is C1-6alkyl, mono- or di(C3-6cycloalkyl)methyl, Ar1CH2, C1-6alkyloxy-C1-6alkyl, hydroxyC1-6alkyl, C3-6alkenyl, thienylmethyl, furanylmethyl, C1-6alkylthioC1-6alkyl, morpholinyl, mono- or di(C1-6alkyl)aminoC1-6alkyl, di(C1-6alkyl)amino, C1-6alkylcarbonylC1-6alkyl, C1-6alkyl substituted with imidazolyl; or a radical of formula -Alk-O—CO-Ar1; or R4 and R5 taken together with the nitrogen atom to which they are attached may form an optionally substituted pyrrolidinyl, piperidinyl, homopiperidinyl or morpholinyl group; Ar is phenyl, substituted phenyl, pyridinyl or substituted pyridinyl; having CRF receptor antagonistic properties; pharmaceutical compositions containing such compounds as active ingredients; methods of treating disorders related to hypersecretion of CRF such as depression, anxiety, substance abuse, by administering an effective amount of a compound of formula (I).
    • 本发明涉及包括立体异构体及其药学上可接受的酸加成盐形式的化合物,其中X是S,SO或SO 2; R1是NR4R5或OR5; R2是C1-6烷基,C1-6烷氧基或C1-6烷硫基; R3是氢,C1-6烷基,C1-6烷基磺酰基,C1-6烷基亚磺酰基或C1-6烷硫基; R4是氢,C1-6烷基,一或二(C3-6环烷基)甲基,C3-6环烷基,C3-6烯基,羟基C1-6烷基,C1-6烷基羰基氧基C 1-6烷基或C 1-6烷氧基C 1-6烷基; R5是C1-6烷基,单或二(C3-6环烷基)甲基,Ar1CH2,C1-6烷氧基-C 1-6烷基,羟基C 1-6烷基,C 3-6烯基,噻吩基甲基,呋喃基甲基,C 1-6烷硫基C 1-6烷基,吗啉基,单或 二(C 1-6烷基)氨基C 1-6烷基,二(C 1-6烷基)氨基,C 1-6烷基羰基C 1-6烷基,被咪唑基取代的C 1-6烷基; 或式-Alk-O-CO-Ar1基团; 或R 4和R 5与它们所连接的氮原子一起可以形成任选取代的吡咯烷基,哌啶基,高哌啶基或吗啉基; Ar是苯基,取代的苯基,吡啶基或取代的吡啶基; 具有CRF受体拮抗特性; 含有这些化合物作为活性成分的药物组合物; 通过施用有效量的式(I)化合物来治疗与CRF过度分泌有关的疾病的方法,例如抑郁症,焦虑症,药物滥用。